Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

De novo discovery of metabolic heterogeneity with immunophenotype-guided imaging mass spectrometry
Verena M. Prade, Thomas Kunzke, Annette Feuchtinger, et al.
Molecular Metabolism (2020) Vol. 36, pp. 100953-100953
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Atlas of exercise metabolism reveals time-dependent signatures of metabolic homeostasis
Shogo Sato, Kenneth A. Dyar, Jonas T. Treebak, et al.
Cell Metabolism (2022) Vol. 34, Iss. 2, pp. 329-345.e8
Open Access | Times Cited: 136
Advances in mass spectrometry imaging for spatial cancer metabolomics
Xin Ma, Facundo M. Fernández
Mass Spectrometry Reviews (2022) Vol. 43, Iss. 2, pp. 235-268
Open Access | Times Cited: 86
Multiplex protein imaging in tumour biology
Natalie de Souza, Shan Zhao, Bernd Bodenmiller
Nature reviews. Cancer (2024) Vol. 24, Iss. 3, pp. 171-191
Closed Access | Times Cited: 27
Multimodal Imaging Mass Spectrometry: Next Generation Molecular Mapping in Biology and Medicine
Elizabeth K. Neumann, Katerina Djambazova, Richard M. Caprioli, et al.
Journal of the American Society for Mass Spectrometry (2020) Vol. 31, Iss. 12, pp. 2401-2415
Open Access | Times Cited: 94
MALDI-MSI Towards Multimodal Imaging: Challenges and Perspectives
Michael Tuck, Florent Grélard, Landry Blanc, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 58
Spatial Metabolomics Identifies Distinct Tumor-Specific Subtypes in Gastric Cancer Patients
Jun Wang, Thomas Kunzke, Verena M. Prade, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 13, pp. 2865-2877
Open Access | Times Cited: 46
Mass spectrometry imaging methods for visualizing tumor heterogeneity
Kyle D. Duncan, Helena Pětrošová, Julian J. Lum, et al.
Current Opinion in Biotechnology (2024) Vol. 86, pp. 103068-103068
Open Access | Times Cited: 8
The fatal trajectory of pulmonary COVID-19 is driven by lobular ischemia and fibrotic remodelling
Maximilian Ackermann, Jan C. Kamp, Christopher Werlein, et al.
EBioMedicine (2022) Vol. 85, pp. 104296-104296
Open Access | Times Cited: 36
Spatial metabolomics for evaluating response to neoadjuvant therapy in non‐small cell lung cancer patients
Jian Shen, Na Sun, Philipp Zens, et al.
Cancer Communications (2022) Vol. 42, Iss. 6, pp. 517-535
Open Access | Times Cited: 30
Visualization of metabolites and microbes at high spatial resolution using MALDI mass spectrometry imaging and in situ fluorescence labeling
Patric Bourceau, Benedikt Geier, Vincent Suerdieck, et al.
Nature Protocols (2023) Vol. 18, Iss. 10, pp. 3050-3079
Closed Access | Times Cited: 22
Metabolic heterogeneity affects trastuzumab response and survival in HER2-positive advanced gastric cancer
Jun Wang, Na Sun, Thomas Kunzke, et al.
British Journal of Cancer (2024) Vol. 130, Iss. 6, pp. 1036-1045
Open Access | Times Cited: 7
Advancing rare cancer research by MALDI mass spectrometry imaging: Applications, challenges, and future perspectives in sarcoma
Maren Nicole Stillger, Mujia Li, Pia Hönscheid, et al.
PROTEOMICS (2024) Vol. 24, Iss. 12-13
Open Access | Times Cited: 7
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section
Vanna Denti, Giulia Capitoli, Isabella Piga, et al.
Journal of Proteome Research (2022) Vol. 21, Iss. 11, pp. 2798-2809
Open Access | Times Cited: 23
An overview of image registration for aligning mass spectrometry imaging with clinically relevant imaging modalities
Benjamin Balluff, Ron M. A. Heeren, Alan Race
Journal of Mass Spectrometry and Advances in the Clinical Lab (2021) Vol. 23, pp. 26-38
Open Access | Times Cited: 32
Next‐generation pathology practices with mass spectrometry imaging
Hsin‐Hsiang Chung, Penghsuan Huang, Chih‐Lin Chen, et al.
Mass Spectrometry Reviews (2022) Vol. 42, Iss. 6, pp. 2446-2465
Closed Access | Times Cited: 21
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective
Zhiqiang Zhang, Chaohui Bao, Jiang Lu, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 12
Metabolomics at the tumor microenvironment interface: Decoding cellular conversations
Naomi Berrell, Habib Sadeghirad, Tony Blick, et al.
Medicinal Research Reviews (2023) Vol. 44, Iss. 3, pp. 1121-1146
Open Access | Times Cited: 11
To image or not to image: Use of imaging mass spectrometry in biomedical lipidomics
Albert Maimó-Barceló, Karim Pérez-Romero, Ramón María Alvargonzález Rodríguez, et al.
Progress in Lipid Research (2025) Vol. 97, pp. 101319-101319
Closed Access
Spatial metabolomics identifies distinct tumor-specific and stroma-specific subtypes in patients with lung squamous cell carcinoma
Jun Wang, Na Sun, Thomas Kunzke, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 8
In tissue spatial single-cell metabolomics by coupling mass spectrometry imaging and immunofluorescences
Landry Blanc, Florent Grélard, Michael Tuck, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
MALDI Mass Spectrometry Imaging—Prognostic Pathways and Metabolites for Renal Cell Carcinomas
Franziska Erlmeier, Na Sun, Jian Shen, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1763-1763
Open Access | Times Cited: 12
Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes
Qian Wang, Na Sun, Raphael Meixner, et al.
JCI Insight (2023) Vol. 8, Iss. 16
Open Access | Times Cited: 6
Inter-organ cross-talk in human cancer cachexia revealed by spatial metabolomics
Na Sun, Tanja Krauss, Claudine Seeliger, et al.
Metabolism (2024), pp. 156034-156034
Open Access | Times Cited: 2
Metabolic Constrains Rule Metastasis Progression
Niccolò Roda, Valentina Gambino, Marco Giorgio
Cells (2020) Vol. 9, Iss. 9, pp. 2081-2081
Open Access | Times Cited: 18
Metabolic tumor constitution is superior to tumor regression grading for evaluating response to neoadjuvant therapy of esophageal adenocarcinoma patients
Achim Buck, Verena M. Prade, Thomas Kunzke, et al.
The Journal of Pathology (2021) Vol. 256, Iss. 2, pp. 202-213
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top